Dr Anand Kamal Singh
Senior Research Scientist
The University of Texas MD Anderson Cancer Center
Texas
Expertise:
Oncology
50
Publications
5
Projects
706
Scopus Citations
817
CrossRef
18 Years 3 Months Total Experience
Scopus
706
Citations
12
h-index
CrossRef
817
Citations
12
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Poster presentation at AACR 2024
2024
San Diego
Flash talk at the Leading Edge of Cancer Research Symposium
2021
MD Anderson Cancer Center
Award for Cytometry Research
2015
The Cytometry Society–India
Travel Grant for the 4th India–Japan Workshop on Cell Engineering and Bioinformatics
2010
IIT Delhi
Senior Research Fellowship (CSIR-SRF
2011
Council of Scientific and Industrial Research (CSIR)
Junior Research Fellowship (CSIR-JRF
2009
Council of Scientific and Industrial Research (CSIR)
All India Rank 93 (99.07 percentile) in GATE 2008
2008
Graduate Aptitude Test in Engineering (GATE)
All India Rank 110 (98.9 percentile) in GATE 2007
2007
Graduate Aptitude Test in Engineering (GATE)
Scholarship for MSc Biotechnology
2006
Department of Biotechnology
All India Rank 16 in the Combined Entrance Examination for MSc Biotechnology
2006
Jawaharlal Nehru University
Community & Membership
Frontiers in Epigenetics and Epigenomics
EditorAmericn Association of Cancer Research
Associate membershipPersonal Details
Doctor of Philosophy
2017
N/A
Master of Science
2008
Mizoram University, Aizwal
Bachelor of Science
2004
ACE Manufacturing Systems Ltd
Senior Research Scientist
Feb 2025 – Present
The University of Texas MD Anderson Cancer Center
Research Scientist
Apr 2022 – Feb 2025
The University of Texas MD Anderson Cancer Center
Post-Doctoral Fellow
Apr 2017 – Apr 2022
The University of Texas MD Anderson Cancer Center
Research Associate
Aug 2016 – Apr 2017
The University of Texas MD Anderson Cancer Center
Senior Research Fellow
Nov 2011 – Aug 2016
National Center for Cell Sciences, Pune
Junior Research Fellow
Nov 2009 – Nov 2011
National Center for Cell Sciences, Pune
Project Fellow
Jun 2008 – Nov 2009
CSIR-Institute of Genomics and Integrative Biology
Medical and Health Sciences
Scholarly Work
Enhancer targeting to reverse CD8+ T-cell exhaustion for cancer immunotherapy
OtherEpigenetic reprogramming of NK-cell dysfunction in AML/MDS
OtherChromatin state dynamics and enhancer subtypes in colorectal cancer
OtherATRX-dependent chromatin organization and therapeutic vulnerabilities in glioma
OtherEpigenetic regulation of ovarian cancer progression and biomarker discovery (PhD
OtherAberrant epigenetic marks in epithelial ovarian cancer progression
Compositions and methods for overcoming T-cell exhaustion
University of Texas System
University of Texas at Austin
-
Application No. :
WO2026019837A1
Filed :
17-07-2024
Published :
22-01-2026
Published
Scholarly Publications
Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance
10.1101/2022.08.31.506051
Crossref: 2
Figure S3 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Open AccessFigure S3 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Open AccessFigure S2 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Open AccessFigure S2 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Open AccessFigure S1 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Open AccessFigure S1 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Open AccessData from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Open Access
Showing 1 to 8 of 50 publications